Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis.

Safety of postoperative administration of human urinary trypsin inhibitor in lung cancer patients with idiopathic pulmonary fibrosis.

Patients with idiopathic pulmonary fibrosis (IPF) undergoing pulmonary resection for lung cancer carry risks of acute exacerbations of IPF (AE) postoperatively. Currently, agents which may attenuate AE are actively sought. Urinary trypsin inhibitor, ulinastatin, is a synthetic glycoprotein which may...

Full description

Bibliographic Details
Main Authors: Yoshikane Yamauchi, Yotaro Izumi, Masanori Inoue, Hiroaki Sugiura, Taichiro Goto, Masaki Anraku, Takashi Ohtsuka, Mitsutomo Kohno, Kenzo Soejima, Hiroaki Nomori
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3245251?pdf=render

Internet

http://europepmc.org/articles/PMC3245251?pdf=render

Similar Items